Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-24 @ 5:38 PM
Last Modification Date: 2025-12-24 @ 5:38 PM
Retention: SAMPLES_WITH_DNA
Description: All enrolled patients will receive additional blood sampling at enrolment (approximately 20 ml) and then at 6 and 12 month of follow-up, during a venopucture performed for the standard laboratory follow-up. Additional samples will be used for assaying a comprehensive array of biomarkers that may provide information regarding immune system activity (T-regs, circulating nanovescicles, microRNA), graft injury (donor-derived cell free DNA), and susceptibility to infection (Quantiferon Monitor; Torque Teno Virus).
Section: All enrolled patients will receive additional blood sampling at enrolment (approximately 20 ml) and then at 6 and 12 month of follow-up, during a venopucture performed for the standard laboratory follow-up. Additional samples will be used for assaying a comprehensive array of biomarkers that may provide information regarding immune system activity (T-regs, circulating nanovescicles, microRNA), graft injury (donor-derived cell free DNA), and susceptibility to infection (Quantiferon Monitor; Torque Teno Virus).